Cyclophosphamide therapy for renal involvement in SLE: When to discontinue in responders? When to consider it has failed?

dc.creator	Vlachoyiannopoulos, P. G.	en
dc.creator	Samarkos, M.	en
dc.creator	Fotia, M.	en
dc.creator	Zintzaras, E.	en
dc.creator	Boletis, J.	en
dc.creator	Moutsopoulos, H. M.	en
dc.date.accessioned	2015-11-23T10:53:50Z
dc.date.available	2015-11-23T10:53:50Z
dc.date.issued	2005
dc.identifier.issn	0004-3591
dc.identifier.uri	http://hdl.handle.net/11615/34549
dc.source	Arthritis and Rheumatism	en
dc.source.uri	<Go to ISI>://WOS:000232207800459
dc.subject	Rheumatology	en
dc.title	Cyclophosphamide therapy for renal involvement in SLE: When to discontinue in responders? When to consider it has failed?	en
dc.type	journalArticle	en

Files in questo item

Files	Dimensione	Formato	Mostra
Nessun files in questo item.